- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05025501
A Randomized Controlled Study of Family Based EF Training for Schoolage Children With ADHD
August 25, 2021 updated by: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Family Based Executive Function Training for Schoolage Children With ADHD - A Randomized Controlled Study
The goal of this study is to provide a new treatment approach for schoolage children with ADHD, which could facilitate the EF developing well to achieve better outcome.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
ADHD in preschoolers has become established as a valid psychiatric disorder with characterized core deficits of executive function (EF).
The EF impairments occurred in preschool period could persist to childhood, adolescent and adulthood, causing extensive and deep damage of individual's academic and career achievement, social function, and peer relationship.
Although medication showed significant effectiveness in controlling the core symptoms of ADHD, it failed to help patients master compensatory strategies to cope with functional impairments in learning and life events.
The family intervention program for school-age ADHD children is still rare, and it is a blank field in China.
At present, most of these related studies have not integrated task training in realistic scenarios with parent training, and lack of randomized and controlled Settings, which makes the effect of intervention less convincing.
Therefore, the investigators conduct this randomized and controlled study to find out the therapeutic efficacy of Family-based Executive Function Training for Schoolage Children with ADHD, and follow the subjects to observe whether the therapeutic efficacy would persist.
In the mean time, the investigators also observe the factors which can influence the therapeutic efficacy.
The goal of this study is to provide a new treatment approach for schoolage children with ADHD, which could facilitate the EF developing well to achieve better outcome.
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Shanghai, China, 200092
- Xinhua Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
7 years to 11 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- meet both the criteria of ADHD based on the interview by the CDIS and clinical diagnosis with DSM-5;
- full-scale IQ estimated bythe Wechsler Intelligence Scale for Children-Revised Form (WISC-R) above 80;
- their parents volunteered to participate in this study.
Exclusion Criteria:
- child with severe mental disorder or physical disease that might interfere the assessment and intervention, such as Autistic Spectrum Disorder(ASD), Schizophrenia, epilepsy, traumatic brain injury, etc.;
- parents with severe mental illness, such as schizophrenia, mood disorder (period of onset), etc..
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
Subjects in this group will receive the "Famliy based Executive Function Training " program in aiming to reduce ADHD symptoms and improve the executive function.
|
Training the executive funtions of shcoolage ADHD children through tasks and games repeatly but with fun.
Giving the parental training and support for the parenting role parents strategies to help the shcoolage ADHD childred coping the symptoms and develop EF in the reallife and improve parent-child relationship.
|
No Intervention: Waiting group
Subjects in this group will not receive the "Famliy based Executive Function Training " program during the study period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The executive function of of schoolage child of ADHD
Time Frame: through the intervention completion, an average of 12 weeks
|
The core symptoms of schoolage children of ADHD assessed by neuropsychological evaluation tool NEPSY
|
through the intervention completion, an average of 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The executive function in real life of schoolage child of ADHD
Time Frame: through the intervention completion, an average of 12 weeks
|
The executive function in real life of schoolage children of ADHD assessed by BRIEF
|
through the intervention completion, an average of 12 weeks
|
The ADHD symptoms of child
Time Frame: through the intervention completion, an average of 12 weeks
|
The ADHD symptoms of child assessed by SNAP
|
through the intervention completion, an average of 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Meihui Qiu, Master, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2021
Primary Completion (Anticipated)
February 6, 2022
Study Completion (Anticipated)
February 6, 2022
Study Registration Dates
First Submitted
August 25, 2021
First Submitted That Met QC Criteria
August 25, 2021
First Posted (Actual)
August 27, 2021
Study Record Updates
Last Update Posted (Actual)
August 27, 2021
Last Update Submitted That Met QC Criteria
August 25, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- XH-21-006
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ADHD
-
The Hong Kong Polytechnic UniversityRecruiting
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Recruiting
-
VIZO Specs LtdRecruiting
-
Loewenstein HospitalWingate InstituteRecruiting
-
Florida State UniversityRecruiting
-
Florida International UniversityRecruiting
-
Region Örebro CountyRecruiting
-
Johns Hopkins UniversityWithdrawn
-
Tris Pharma, Inc.Premier Research Group plcCompleted
Clinical Trials on Family based Executive Function Training
-
Xinhua Hospital, Shanghai Jiao Tong University...Recruiting
-
University of Missouri, Kansas CityUniversity of KansasUnknownPosttraumatic Stress DisordersUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...Completed
-
ZIli FanUnknown
-
Concordia University, MontrealCanadian Institutes of Health Research (CIHR)RecruitingAging | Age Related Hearing LossCanada
-
CogCubed, CorpOhio UniversityCompletedAutism Spectrum Disorder | Attention Deficit Hyperactivity Disorder | Asperger's Disorder | Pervasive Developmental DisorderUnited States
-
Kessler FoundationNational Institute on Disability, Independent Living, and Rehabilitation...RecruitingTBI (Traumatic Brain Injury)United States
-
BaycrestSunnybrook Health Sciences CentreUnknownTransient Ischemic Attack | Mild Stroke | Ischemic White Matter Disease | Stroke RiskCanada
-
University of BarcelonaFundació La Marató de TV3Completed